ASGCT 2020 Election Open Through April 10

ASGCT Staff - March 18, 2020

All full and transitional members are eligible to vote for the five open positions on the Board of Directors.

The American Society of Gene & Cell Therapy will welcome five new members to the ASGCT Board of Directors this spring. All full and transitional members are eligible to participate. Learn more about the candidiates and vote online now through April 10 and use your voice to direct ASGCT's path forward.

Vote Today in the Members-Only Area of

Here are the 2020 candidates:

Vice President (Term of Office: 2020-2021)

Hans-Peter Kiem, MD, PhD

Fred Hutchinson Cancer Research Center

David Schaffer, PhD

University of California-Berkeley


Treasurer (2020-2023)

Paloma Giangrande, PhD

Moderna Therapeutics

Rachel Salzman, DVM

SwanBio Therapeutics


At-Large Director (2020-2023)

Marcela Maus, MD, PhD

Harvard University

Feng Zhang, PhD

Massachusetts Institute of Technology


At-Large Director (2020-2023)

Alessandro Aiuti, MD, PhD

Ospedale San Raffaele

Federico Mingozzi, PhD

Spark Therapeutics


At-Large Director, Scientific & Research Council Chair (2020-2023)

Alberto Auricchio, MD

Telethon Institute of Genetics and Medicine

Anastasia Khvorova, PhD

University of Massachusetts Medical School

Share This Page

Related Articles


There's Still Time to Renew Your Membership

ASGCT Staff - March 05, 2020

Six ASGCT Members Earn Career Development Awards

ASGCT Staff - October 23, 2019

ASGCT Education Program Returns, Covers Parkinson's Disease

ASGCT Staff - October 10, 2019

Molecular Therapy Impact Factors Jump Nearly 28 Percent Across Family of Titles

ASGCT Staff - June 26, 2019